Structural basis of BMP signaling inhibition by Noggin, a novel twelve-membered cystine knot protein

Journal of Bone and Joint Surgery

Volumn 85, Issue SUPPL. 3, 2003, Pages 52-58

  Groppe, Jay ^a   Greenwald, Jason ^b   Wiater, Ezra ^b   Rodriguez Leon, Joaquin ^b   Economides, Aris N ^b   Kwiatkowski, Witek ^b   Baban, Kandan ^b   Affolter, Markus ^b   Vale, Wylie W ^b   Izpisua Belmonte, Juan Carlos ^b   Choe, Senyon ^b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CYSTINE; NOGGIN; OSTEOGENIC PROTEIN 1; PROTEIN INHIBITOR;

ANIMAL TISSUE; BINDING AFFINITY; BONE DYSPLASIA; COMPLEX FORMATION; CONFERENCE PAPER; CRYSTAL STRUCTURE; DRUG SCREENING; GENE LOCUS; GENETIC ASSOCIATION; LIMB BUD; MISSENSE MUTATION; MULTIPLE SYNOSTOSES SYNDROME; NONHUMAN; OSSIFYING MYOSITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN VARIANT; SIGNAL TRANSDUCTION; SYMPHALANGIA; TARSAL CARPAL COALITION SYNDROME;

EID: 0041633631     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-200300003-00010     Document Type: Conference Paper

References (30)

1. Urist MR. Bone: formation by autoinduction. Science. 1965;150:893-9.
2. Hogan BL. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 1996;10:1580-94.
3. Hogan BL. Bone morphogenetic proteins in development. Curr Opin Genet Dev. 1996;6:432-8.
4. Massague J. TGF-β signal transduction. Annu Rev Biochem. 1998;67:753-91.
5. Smith WC, Harland RM. Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell 1992;70:829-40.
6. Hsu DR, Economides AN, Wang X, Elmon PM, Harland RM. The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1998;1:673-83.
7. Piccolo S, Sasal Y, Lu B, De Robertis EM. Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell. 1996;86:589-98.
8. Brunet U, McMahon JA, McMahon AP, Harland RM. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science. 1998;280:1455-7.
9. Gong Y, Krakow D, Marcelino J, Wilkin D, Chitayat D, Babul-Hirji R, Hudgins L, Cremers CW, Cremers FP, Brunner HG, Reinker K, Rimoln DL, Cohn DH, Goodman FR, Reardon W, Patton M, Francomano CA, Warman ML. Heterozygous mutations in the gene encoding noggin affect human joint morphogenesis. Nat Genet. 1999;21:302-4.
10. Lim DA, Tramontin AD, Trevejo JM, Herrera DG, Garcia-Verdugo JM, Alvarez-Buylla A. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron. 2000;28:713-26.
11. Sampath TK, Mallakal JC, Hauschka PV, Jones WK, Sasak H, Tucker RF, White KH, Coughlin JE, Tucker MM, Pang RH, Corbett C, Ozkaynak E, Oppermann H, Rueger DC. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem. 1992;267:20352-62.
12. Valenzuela DM, Economides AN, Rojas E, Lamb TM, Nunez L, Jones P, Lp NY, Espinosa R 3rd, Brannan CI, Gilbert DJ. Identification of mammalian noggin and its expression in the adult nervous system. J Neurosci. 1995;15:6077-84.
13. Groppe J, Greenwald J, Wiater E, Rodriguez-Leon J, Economides AN, Kwiatkowski W, Affolter M, Vale WW, Belmonte JC, Choe S. Structural basis of BMP signalling inhibition by the cystine knot protein Noggin. Nature. 2002;420:636-42.
14. Griffith DL, Keck PC, Sampath TK, Rueger DC, Carlson WD. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. Proc Natl Acad Sci USA. 1996;93:878-83.
15. Vitt UA, Hsu SY, Hsueh AJ. Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules. Mol Endocrinol. 2001;15:681-94.
16. Kirsch T, Sebald W, Dreyer MK. Crystal structure of the BMP-2-BRIA ectodomain complex. Nat Struct Biol. 2000;7:492-6.
17. Greenwald J, Groppe J, Gray P, Wiater E, Kwiatkowski W, Vale W, Choe S. The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. Mol Cell. 2003;11:605-17.
18. Palne-Saunders S, Viviano BL, Economides AN, Saunders S. Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients. J Biol Chem. 2002;277:2089-96.
19. Groppe J, Rumpel K, Economides AN, Stahl N, Sebald W, Affolter M. Biochemical and biophysical characterization of refolded Drosophila DPP, a homolog of bone morphogenetic proteins 2 and 4. J Biol Chem. 1998;273:29052-65.
20. Zimmerman LB, De Jesus-Escobar JM, Harland RM. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell. 1996;86:599-606.
21. Dixon ME, Armstrong P, Stevens DB, Bamshad M. Identical mutations in NOG can cause either tarsal/carpal coalition syndrome or proximal symphalangism. Genet Med. 2001;3:349-53.
22. Takahashi T, Takahashi I, Komatsu M, Sawaishi Y, Higashi K, Nishimura G, Saito H, Takada G. Mutations of the NOG gene in individuals with proximal symphalangism and multiple synostosis syndrome. Clin Genet. 2001;60:447-51.
23. Marcelino J, Sciortino CM, Romero MF, Ulatowski LM, Ballock RT, Economides AN, Elmon PM, Harland RM, Warman ML. Human disease-causing NOG missense mutations: effects on noggin secretion, dimer formation, and bone morphogenetic protein binding. Proc Natl Acad Sci USA. 2001;98:11353-8.
24. Mangino M, Flex E, Digillo MC, Giannotti A, Dallapiccola S. Identification of a novel NOG gene mutation (P35S) in an Italian family with symphalangism. Hum Mutat. 2002;19:308.
25. Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med. 1996;335:555-61.
26. Xu MQ, Feldman G, Le Merrer M, Shugart YY, Glaser DL, Urtizberea JA, Fardeau M, Connor JM, Triffitt J, Smith R, Shore EM, Kaplan FS. Linkage exclusion and mutational analysis of the noggin gene in patients with fibrodysplasia ossificans progresslva (FOP). Clin Genet. 2000;58:291-8.
27. Warman ML. Significant difference of opinion regarding the role of noggin in fibrodysplasla ossificans progressiva. Am J Med Genet. 2002;109:162-4.
28. Xu MQ, Shore EM, Kaplan FS. Reported noggin mutations are PCR errors. Am J Med Genet. 2002;109:161.
29. Economides A, Stahl NE, Harland RM, inventors; Regeneron Pharmaceuticals, assignee. Modified noggin polypeptide and compositions. United States patent 6075007. 1997 July 17.
30. Economides AN, Glaser DL, Wang L, Liu X, Kimble RD, Fandi JP, Wilson JP, Stahl N, Kaplan FS, Shore EM. In vivo somatic cell gene transfer of an engineered noggin mutein prevents BMP4-induced heterotopic ossification in the mouse: implications for the treatment of disorders of heterotopic ossification. J Bone Joint Surg Am, in press.